Integra LifeSciences Holdings (IART)

Financial leverage ratio

Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020
Total assets US$ in thousands 4,037,420 3,781,990 3,889,760 3,782,380 3,615,140
Total stockholders’ equity US$ in thousands 1,545,280 1,587,880 1,804,400 1,684,800 1,514,870
Financial leverage ratio 2.61 2.38 2.16 2.25 2.39

December 31, 2024 calculation

Financial leverage ratio = Total assets ÷ Total stockholders’ equity
= $4,037,420K ÷ $1,545,280K
= 2.61

The financial leverage ratio for Integra LifeSciences Holdings has shown a declining trend over the past five years, decreasing from 2.39 in December 2020 to 2.61 in December 2024. This indicates that the company's reliance on debt has been relatively stable, with a slight increase in leverage in 2024. It is essential to monitor this ratio as a high financial leverage ratio may indicate increased financial risk due to higher debt levels, while a low ratio may imply underutilization of debt financing opportunities.